scispace - formally typeset
I

Isabelle Lemasson

Researcher at East Carolina University

Publications -  41
Citations -  1595

Isabelle Lemasson is an academic researcher from East Carolina University. The author has contributed to research in topics: Transcription (biology) & Transcription factor. The author has an hindex of 23, co-authored 38 publications receiving 1451 citations. Previous affiliations of Isabelle Lemasson include Centre national de la recherche scientifique & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Human T-Cell Leukemia Virus Type 1 (HTLV-1) bZIP Protein Interacts with the Cellular Transcription Factor CREB To Inhibit HTLV-1 Transcription

TL;DR: HBZ reduces HTLV-1 transcription and virion production, and the interaction between HBZ and the cellular transcription factor CREB is characterized, suggesting that HBZ may deregulate CREB-dependent cellular gene expression.
Journal ArticleDOI

Binding of p53 to the KIX Domain of CREB Binding Protein A POTENTIAL LINK TO HUMAN T-CELL LEUKEMIA VIRUS, TYPE I-ASSOCIATED LEUKEMOGENESIS

TL;DR: This report identifies the KIX domain as a new p53 contact point on CBP and demonstrates that the activation domain of p53 participates in KIX binding and provides evidence showing that this interaction is critical for p53 transactivation function.
Journal ArticleDOI

CREB-2, a Cellular CRE-Dependent Transcription Repressor, Functions in Association with Tax as an Activator of the Human T-Cell Leukemia Virus Type 1 Promoter

TL;DR: It is demonstrated that CREB-2 cooperates with Tax to enhance viral transcription and that its basic-leucine zipper C-terminal domain is required for both in vitro and in vivo interactions with Tax.
Journal ArticleDOI

p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation.

TL;DR: It is proposed that phosphorylated CREB mediates recruitment of CBP to p53-responsive promoters through direct interaction with p53, providing evidence for a novel pathway that integrates cAMP signaling and p53 transcriptional activity.